icarrin has been researched along with Osteoporosis* in 2 studies
2 other study(ies) available for icarrin and Osteoporosis
Article | Year |
---|---|
[Activity Study of Icarlin and Epimedin C Monomer under the Same Molarity in Osteoporosis Ze- brafish Model].
Objective To evaluate anti-osteoporotic activity of icariin and Epimedin C monomer under the same molarity in predinsolone-induced osteoporosis zebrafish. Methods Zebrafish larvae after 4-day fertilization were divided into group S [0. 5% dimethyl sulfoxide (DMSO) , A (25 μmol/L prednisolone, 0. 5% DMSO), B (2 IU/L salmon calcitonin, 25 μmol/L prednisolone,0. 5% DMSO), C (1. 5 1,mol/L icariin, 25 μmol/L prednisolone, 0. 5% DMSO) , D (15 μLmol/L icariin,25 μmol/L prednisolone, 0. 5% DM- SO), E (150 μmol/L icariin, 25 μmol/L prednisolone, 0. 5% DMSO), F (1. 5 μmol/L Epimediri C, 25 μmol/L prednisolone, 0. 5% DMSO) , G (15 μmol/L Epimedin C, 25 μmol/L prednisolone, 0.5% DM- SO) , H (150 μmol/L Epimedin C, 25 μmol/L prednisolone, 0. 5% DMSO). All culture solution contained 0. 5% DMSO. All the young fishes were grown in a 24-well plate. The culture medium was changed every day. They were cultured in a incubator box at 28. 5 °C and killed at day 9. Zebrafish skeleton was stained with alizarin red. The stained Zebrafish ventral skull was observed using microscope, and mineralized area was quantitatively analyzed. Results Compared with group S, accumulative integrated optical densi- ty(IOD)of the mineralized area significantly decreased in group A (P <0. 01) ; accumulative IOD of the mineralized area significantly increased in group B (P <0. 01). The accumulative IOD of the mineralized area showed weakly increasing tendency in group C, D, and E along with increased concentration (P < 0. 05). Compared with group A, accumulative IOD obviously increased in group B with statistical difference (P <0. 01) , but with no statistical difference as compared with group C or group D (P >0. 05). Statistical difference existed in accumulative IOD between group A and group E (P <0. 05). The mineralized area showed increasing tendency in group F and group G along with increased concentration (P <0. 05), and accumulative IOD obviously increased as well (P <0. 05). No Zebrafish embryo survived in group H. There was no statistical difference in Zebrafish embryo survival among group E, F, or G (P >0. 05). The staining of Zebrafish skull was clearly seen in group S, with vertebrae and bilateral branchial skeleton clearly seen. The intensity of staining in the same area was obviously attenuated in group A. The osteo- genesis was speeded up under the same condition in group B, with obviously enlarged mineralized area and more darkly stained bone tissue. The mineralization of skull was Topics: Animals; Disease Models, Animal; Flavonoids; Glucosides; Osteoporosis; Zebrafish | 2016 |
A cell-based model of bone remodeling for identifying activity of icarrin in the treatment of osteoporosis.
The activity of icarrin (a flavonoid from Herba epimedii) was investigated in the regulation of bone remodeling, a process coupled by osteoblast-mediated bone forming and osteoclast-mediated bone resorption. By directly co-culturing mouse bone marrow stromal cells and mouse preosteoclastic RAW264.7, and transwell co-culturing rat ovarian follicular granulosa cells (FGC), a 30 % increase in alkaline phosphatase (ALP) activity and 25 % increase in estradiol level occurred. Compared with the antiresorptive drug, alendronate, and an anabolic drug, PTH1-34, icarrin possessed all of the positive effects on the co-culture by increasing ALP activity, estradiol production and decreasing tartrate-resistant acid phosphatase activity. A similar action of icarrin occurred on co-culture of mesenchymal stem cells, mouse peripheral blood mononuclear cells, and FGC. Overall, by using a co-cultured cell-based in vitro screening assay, icarrin is suggested as a new class of dual-action therapeutic agent for osteoporosis. Topics: Alendronate; Animals; Bone Remodeling; Cell Line; Epimedium; Flavonoids; Glucosides; Mice; Mice, Inbred BALB C; Models, Biological; Osteoporosis; Parathyroid Hormone; Plant Extracts | 2015 |